martes, 5 de noviembre de 2019

Amgen acquires stake in BeiGene to grow cancer drug business to China

Amgen acquires stake in BeiGene to grow cancer drug business to China

Cancer Briefing

Amgen acquires stake in BeiGene to expand cancer drug business to China

By ADAM FEUERSTEIN


RUBY WALLAU FOR STAT
For BeiGene, the partnership bolsters its existing commercial operations in China, which already sells certain cancer medicines owned by Celgene.

No hay comentarios: